Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Cancer|March 15, 2006
Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infectionLaurence Fardet, Pierre-Emmanuel Stoebner, Herve Bachelez, et al.Journal of the American Academy of Dermatology|March 15, 2017
Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III studyKim Papp, Herve Bachelez, Antonio Costanzo, et al.Dermatology (Basel, Switzerland)|December 9, 2021
A Multicentre Randomised Controlled Study Evaluating the Effect of a Standardised Education Programme on Quality of Life, Disease Severity, and Disease Knowledge in Patients with Moderate-To-Severe Psoriasis: The EDUPSO StudyFatma Jendoubi, Stefana Balica, Marie Aleth Richard, et al.The New England Journal of Medicine|October 1, 2015
Phase 3 Studies Comparing Brodalumab with Ustekinumab in PsoriasisMark Lebwohl, Bruce Strober, Alan Menter, et al.The British Journal of Dermatology|February 10, 2023
Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional surveySophia Quirke-McFarlane, John Weinman, Emma S Cook, et al.Pageof 1